Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Ann Neurol. 2018 Sep;84(3):452–462. doi: 10.1002/ana.25303

FIGURE 1:

FIGURE 1:

(A) The tumor necrosis factor α (TNFα) secretion in ex vivo human cerebral adrenoleukodystrophy (cALD) monophagocytic cells in dose response to very long-chain fatty acid (VLCFA) stimulation. The labeled doses show C24:0 levels. The C26:0 level is 1/10th of the C24:0 dose. (B) Healthy control, adrenomyeloneuropathy (AMN), and cerebral response to lipopolysaccharide (LPS) and VLCFA stimulation.